Pharma Mar | PHM - Umlaufvermögen

Aktienkurs
102.80
Täglich Wechseln
-0.50 -0.48%
Monatlich
14.73%
Jährlich
39.30%
Q2 Prognose
93.55




Umlaufvermögen Veränderung Datum
Akebia Therapeutics USD 243.48M 9.47M 2026-03
Alaunos Therapeutics USD 1.99M 697K 2025-12
Almirall EUR 713.98M 69K 2025-12
Avita Medical AUD 35.49M 760K 2025-12
Dianthus Therapeutics USD 1.12B 710.47M 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
IQVIA Holdings USD 6.22B 29M 2026-03
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Moderna USD 5.77B 774M 2026-03
Organon & Co USD 4.93B 580M 2026-03
Pharma Mar EUR 273.45M 9.96M 2026-03
Revvity USD 2.13B 111.43M 2026-03
Tectonic Therapeutic USD 257.36M 15.88M 2025-12
Viatris USD 10.92B 1.13B 2026-03
Xeris Pharmaceuticals USD 240.31M 16.3M 2025-12